mci-196 has been researched along with Body Weight in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kadonosono, K; Muraoka, T; Ogihara, K; Terauchi, Y; Utsunomiya, H; Yamakawa, T | 1 |
Awata, T; Hosaka, T; Inukai, K; Katayama, S; Kurihara, S; Nakamoto, H; Neda, T; Ono, H | 1 |
Kanai, S; Miyashita, Y; Oyama, T; Sasaki, H; Shirai, K | 1 |
Babaya, N; Fujisawa, T; Hiromine, Y; Ikegami, H; Itoi-Babaya, M; Kawabata, Y; Kobayashi, M; Nojima, K; Noso, S; Ogihara, T; Shibata, M; Yamaji, K | 1 |
Futami-Suda, S; Igari, Y; Kigawa, Y; Matsumura, N; Nakano, H; Oba, K; Ouchi, M; Suzuki, K; Suzuki, T; Watanabe, K | 1 |
Inoue, M; Koike, K; Murakami, K; Nozaki, N; Sugiura, K | 1 |
2 trial(s) available for mci-196 and Body Weight
Article | Year |
---|---|
Hypoglycemic effects of colestimide on type 2 diabetic patients with obesity.
Topics: Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Epichlorohydrin; Female; Humans; Hypoglycemic Agents; Imidazoles; Insulin Resistance; Male; Middle Aged; Obesity; Pilot Projects; Resins, Synthetic; Treatment Outcome | 2012 |
Colestilan, a new bile acid-sequestering resin, reduces bodyweight in postmenopausal women who have dieted unsuccessfully.
Topics: Appetite Depressants; Bile Acids and Salts; Body Mass Index; Body Weight; Drug Administration Schedule; Eating; Female; Humans; Middle Aged; Obesity; Postmenopause; Treatment Outcome | 2005 |
4 other study(ies) available for mci-196 and Body Weight
Article | Year |
---|---|
Colestimide improves glycemic control via hepatic glucose production in db/db mice.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Eating; Epichlorohydrin; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Hypoglycemic Agents; Imidazoles; Insulin Resistance; Liver; Mice; Mice, Inbred C57BL; Resins, Synthetic | 2014 |
Usefulness of preheparin lipoprotein lipase mass as a parameter for predicting the efficacy of colestimide.
Topics: Anion Exchange Resins; Body Weight; Cholesterol; Epichlorohydrin; Female; Humans; Hyperlipidemias; Imidazoles; Lipoprotein Lipase; Male; Middle Aged; Resins, Synthetic; Treatment Outcome; Triglycerides | 2005 |
Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin.
Topics: Adipose Tissue; Animals; Anticholesteremic Agents; Blood Glucose; Body Weight; Carrier Proteins; Cholestyramine Resin; Diabetes Mellitus, Type 2; Disease Models, Animal; Epichlorohydrin; Fasting; Fatty Liver; Humans; Hyperlipidemias; Imidazoles; Insulin Resistance; Membrane Glycoproteins; Mice; Obesity; Resins, Synthetic; Weight Gain | 2007 |
Effects of colestimide on blood glucose-lowering activity and body weight in patients with type 2 diabetes and hypercholesterolemia.
Topics: Anion Exchange Resins; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Epichlorohydrin; Humans; Hypercholesterolemia; Imidazoles; Lipids; Resins, Synthetic | 2007 |